Clinically Approved Iron Chelators Influence Zebrafish Mortality, Hatching Morphology and Cardiac Function

Human cardiotoxic drugs delivered by soaking and microinjection induce cardiovascular toxicity in zebrafish

(2013) Jun-Jing Zhu et al.   JOURNAL OF APPLIED TOXICOLOGY

Design of iron chelators with therapeutic application

(2012) Tao Zhou et al.   DALTON TRANSACTIONS

Systematic Approaches to Toxicology in the Zebrafish

(2011) Randall T. Peterson et al.   Annual Review of Pharmacology and Toxicology

Deferasirox: pharmacokinetics and clinical experience

(2011) Renzo Galanello et al.   Expert Opinion on Drug Metabolism & Toxicology

Effects of deferasirox on renal function and renal epithelial cell death

(2011) Penélope D. Sánchez-González et al.   TOXICOLOGY LETTERS

Safety issues of iron chelation therapy in patients with normal range iron stores including thalassaemia, neurodegenerative, renal and infectious diseases

(2010) G J Kontoghiorghes et al.   Expert Opinion On Drug Safety

Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study

(2010) Norbert Gattermann et al.   LEUKEMIA RESEARCH

Fanconi syndrome in a patient with β-thalassemia major after using deferasirox for 27 months

(2010) Hsin-Yi Wei et al.   TRANSFUSION

Dietary iron alters waterborne copper-induced gene expression in soft water acclimated zebrafish (Danio rerio)

(2008) Paul M. Craig et al.   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY

Iron chelating agents for the treatment of iron overload

(2007) Guido Crisponi et al.   COORDINATION CHEMISTRY REVIEWS